ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...
To earn CME related to this news article, click here. February 19, 2009 — The US Food and Drug Administration (FDA) has approved dexlansoprazole for the healing and maintenance healing of erosive ...
Pregnancy and surgery patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting protein. Results from a study by researchers ...
BOSTON, Mass., July 16, 2009- Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results